The American College of Physicians today released a new policy paper calling for changes that could slow the rising cost of prescription drugs. The paper, 'Stemming the Escalating Cost of Prescription Drugs,' was published in Annals of Internal Medicine.
Every day, more than 15 million unpaid caregivers provide care to people with Alzheimer's disease, with little outside support and often at the risk of their own health.
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology. Blood Advances™ will offer a unique focus on scholarly and educational content that complements and expands on topics beyond the scope addressed in Blood. An online platform that provides opportunities for increased communication between authors and readers will be a hallmark of ASH's new publication.
The University of Nottingham is launching a new project to tackle tuberculosis, using IBM's World Community Grid -- one of world's most powerful, virtual, super computers.
Topics range from Computational Connectomics to Transfinite Geometry / Approximately 108 million euros for three years.
The National Science Foundation (NSF), in partnership with the American Association of Community Colleges (AACC), has named 10 finalists for the second annual Community College Innovation Challenge, which fosters the development of crucial innovation skills among students.
A Wayne State University startup company announced today the first successful dosing of a patient in a clinical trial that is a major step forward for patients with vision challenges. RetroSense Therapeutics LLC, a privately held biopharmaceutical company, successfully dosed their first patient in the first clinical trial to evaluate the safety of RST-001. The study is titled 'Phase I/IIa, Open-Label, Dose-Escalation Study of Safety and Tolerability of Uniocular Intravitreal RST-001 in Patients with Retinitis Pigmentosa (RP).'
A team of engineers from Saarland University are developing intelligent motor systems that function without the need for additional sensors. By essentially transforming the motor itself into a sensor, the team led by Professor Matthias Nienhaus are creating smart motors that can tell whether they are still running smoothly, can communicate and interact with other motors and can be efficiently controlled.
Funded by the Gates Foundation and Wellcome Trust, the team aims to sequence 100,000 TB genomes to build reference database of drug resistance genes to speed choice of treatment for multi drug resistant TB.
The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.